0

WHY THIS MATTERS IN BRIEF

Lots of people suffer from bone problems and this new computer could help track disease progression as well as help develop more effective personalised treatment plans.

 

Love the Exponential Future? Join our XPotential Community, future proof yourself with courses from XPotential University, read about exponential tech and trendsconnect, watch a keynote, or browse my blog.

 

“As a surgeon, I am most excited about using measurements collected with osseosurface electronics to someday provide my patients with individualized orthopedic care—with the goal of accelerating rehabilitation and maximizing function after traumatic injuries,” says David Margolis, an assistant professor of orthopedic surgery in the University of Arizona (UA) and orthopedic surgeon at Banner University Medical Center Tucson.

 

RELATED
Chinese researchers trial the worlds first cancer vaccine on humans

 

Margolis is co-senior author of a paper describing the devices in Nature Communications.

Few people know that bone “fragility fractures,” which are associated with conditions like osteoporosis, account for more days spent in the hospital than heart attacks, breast cancer, or prostate cancer combined, and although not yet tested or approved for use in humans the team behind the wireless bone device believe they could one day be used not only to monitor bone health, but to improve it, says co-senior author Philipp Gutruf, an assistant professor at UA.

“Being able to monitor the health of the musculoskeletal system is super important,” says Gutruf, who is also a member of the university’s BIO5 Institute. “With this interface, you basically have a computer on the bone. This technology platform allows us to create investigative tools for scientists to discover how the musculoskeletal system works and to use the information gathered to benefit recovery and therapy.”

 

RELATED
Scientists unveil a brand new smart contact lens that tracks health and detects disease

 

Because muscles are so close to bones and move so frequently, it is important that the device be thin enough to avoid irritating surrounding tissue or becoming dislodged, Gutruf explains.

 

 

“The device’s thin structure, roughly as thick as a sheet of paper, means it can conform to the curvature of the bone, forming a tight interface,” says Alex Burton, a doctoral student in biomedical engineering and co-first author of the study. “They also do not need a battery. This is possible using a power casting and communication method called near-field communication, or NFC, which is also used in smartphones for contactless pay.”

 

RELATED
New Australian heat tolerant COVID-19 vaccine heads to human trials

 

The outer layers of bones shed and renew just like the outer layers of skin. So, if a traditional adhesive was used to attach something to the bone, it would fall off after just a few months. To address this challenge, co-author John Szivek, a professor of orthopedic surgery and biomedical engineering and BIO5 Institute member, developed an adhesive that contains calcium particles with an atomic structure similar to bone cells, which is used as to secure osseosurface electronics to the bone.

“The bone basically thinks the device is part of it, and grows to the sensor itself,” Gutruf says. “This allows it to form a permanent bond to the bone and take measurements over long periods of time.”

 

RELATED
Hundreds of US banks just adopted an automated cyber defense framework

 

For instance, a doctor could attach the device to a broken or fractured bone to monitor the healing process. This could be particularly helpful in patients with conditions such as osteoporosis since they frequently suffer re-fractures. Knowing how quickly and how well the bone is healing could also inform clinical treatment decisions, such as when to remove temporary hardware like plates, rods, or screws.

Some patients are prescribed drugs designed to speed up bone healing or improve bone density, but these prescriptions can have side effects. Close bone monitoring would allow physicians to make more informed decisions about drug dosage levels.

Source: University of Arizona

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, Bloomberg, CNBC, Discovery, RT, Viacom, and WIRED, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Aon, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.

Your email address will not be published. Required fields are marked *